Lipocine Inc.LPCNNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank57
3Y CAGR+44.9%
5Y CAGR-7.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+44.9%/yr
vs -23.9%/yr prior
5Y CAGR
-7.3%/yr
Recent acceleration
Acceleration
+68.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.35M | -0.0% |
| 2024 | $12.35M | +151.9% |
| 2023 | $4.90M | +20.7% |
| 2022 | $4.06M | -23.8% |
| 2021 | $5.33M | -70.4% |
| 2020 | $18.00M | +221.5% |
| 2019 | $5.60M | -53.7% |
| 2018 | $12.09M | -42.4% |
| 2017 | $20.98M | +10.6% |
| 2016 | $18.97M | - |